Skip to Main Navigation
Skip to Page Content

Nomination Summary for Quinidine (N79313)

Nominated Substances: Quinidine

Nomination Date: 09/00/1979

Nominator: NCI

Rationale: Quinidine was nominated based on the interest of the FDA in seeing this drug tested in the NCI bioassay and the lack of carcinogenicity data on this drug. Quinidine is an anti-arrhythmic and cardiotonic drug.

NTP Principles: not specified

Agents and Status

The following information relates to the specific agent and may include history from earlier or later nominations for this same agent.

CASRN: 56-54-2

Agent Name: Quinidine